Vitamin D depletion aggravates hypertension and target-organ damage
- PMID: 25630909
- PMCID: PMC4345870
- DOI: 10.1161/JAHA.114.001417
Vitamin D depletion aggravates hypertension and target-organ damage
Abstract
Background: We tested the controversial hypothesis that vitamin D depletion aggravates hypertension and target-organ damage by influencing renin.
Methods and results: Four-week-old double-transgenic rats (dTGR) with excess angiotensin (Ang) II production due to overexpression of the human renin (hREN) and angiotensinogen (hAGT) genes received vitamin D-depleted (n=18) or standard chow (n=15) for 3 weeks. The depleted group had very low serum 25-hydroxyvitamin D levels (mean±SEM; 3.8±0.29 versus 40.6±1.19 nmol/L) and had higher mean systolic BP at week 5 (158±3.5 versus 134.6±3.7 mm Hg, P<0.001), week 6 (176.6±3.3 versus 162.3±3.8 mm Hg, P<0.01), and week 7 (171.6±5.1 versus 155.9±4.3 mm Hg, P<0.05). Vitamin D depletion led to increased relative heart weights and increased serum creatinine concentrations. Furthermore, the mRNAs of natriuretic peptides, neutrophil gelatinase-associated lipocalin, hREN, and rRen were increased by vitamin D depletion. Regulatory T cells in the spleen and in the circulation were not affected. Ang metabolites, including Ang II and the counter-regulatory breakdown product Ang 1 to 7, were significantly up-regulated in the vitamin D-depleted groups, while ACE-1 and ACE-2 activities were not affected.
Conclusions: Short-term severe vitamin D depletion aggravated hypertension and target-organ damage in dTGR. Our data suggest that even short-term severe vitamin D deficiency may directly promote hypertension and impacts on renin-angiotensin system components that could contribute to target-organ damage. The findings add to the evidence that vitamin D deficiency could also affect human hypertension.
Keywords: hypertension; renin; vitamin D.
© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures
References
-
- Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo‐Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL. Iom committee members respond to endocrine society vitamin D guideline. J Clin Endocrinol Metab. 2012; 97:1146-1152. - PMC - PubMed
-
- Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P. Optimal vitamin D status: a critical analysis on the basis of evidence‐based medicine. J Clin Endocrinol Metab. 2013; 98:E1283-E1304. - PubMed
-
- Forman JP, Giovannucci E, Holmes MD, Bischoff‐Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25‐hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49:1063-1069. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
